At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Hepatic Affection in Hemodialysis Patients With Iron Overload in Assiut University Hospital
In Brief
An observational study for Hepatic Injury. Completed, enrolled 80 participants across 1 site.
Detailed Summary
Aim of the work 1. Assessment of hepatic affection in patients with ESRD (end stage renal disease) on regular dialysis with iron indices suggesting iron overload. 2. Comparison between HCV -negative HD patients with high and normal TSAT as regard liver iron concentration(LIC) and degree of fibrosis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHepatic Injury
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJan 2019
Primary CompletionJan 2020
Study CompletionDec 2020
First PostedAug 2021
TodayJul 2026
First PostedAug 31, 2021
Enrollment StartJan 20, 2019
Primary CompletionJan 30, 2020
Study CompletionDec 30, 2020
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 4.8 years ago